
GlaxoSmithKline Vaccines has signed a deal with US not-for-profit biotech Aeras to develop a new vaccine which will treat tuberculosis …
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions

